Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
VISTA PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
VISTA PHARMA Mar-23 |
TEVA PHARMA Dec-13 |
VISTA PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 14 | 3,483 | - | |
Low | Rs | 7 | 3,026 | - | |
Sales per share (Unadj.) | Rs | 0.3 | 1,998.8 | - | |
Earnings per share (Unadj.) | Rs | -1.5 | 124.9 | - | |
Cash flow per share (Unadj.) | Rs | -1.3 | 286.4 | - | |
Dividends per share (Unadj.) | Rs | 0 | 109.31 | - | |
Avg Dividend yield | % | 0 | 3.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 8.1 | 2,220.3 | - | |
Shares outstanding (eoy) | m | 37.56 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 39.1 | 1.6 | 2,404.0% | |
Avg P/E ratio | x | -6.9 | 26.1 | -26.6% | |
P/CF ratio (eoy) | x | -7.8 | 11.4 | -68.5% | |
Price / Book Value ratio | x | 1.3 | 1.5 | 87.7% | |
Dividend payout | % | 0 | 87.5 | -0.0% | |
Avg Mkt Cap | Rs m | 393 | 2,759,528 | 0.0% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 5 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,712.8 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,355.9 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 10 | 1,695,000 | 0.0% | |
Other income | Rs m | 4 | 0 | - | |
Total revenues | Rs m | 14 | 1,695,000 | 0.0% | |
Gross profit | Rs m | -44 | 464,177 | -0.0% | |
Depreciation | Rs m | 6 | 137,008 | 0.0% | |
Interest | Rs m | 12 | 33,293 | 0.0% | |
Profit before tax | Rs m | -59 | 293,876 | -0.0% | |
Minority Interest | Rs m | 0 | 1,335 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,913 | -0.0% | |
Tax | Rs m | -2 | -3,588 | 0.1% | |
Profit after tax | Rs m | -57 | 105,885 | -0.1% | |
Gross profit margin | % | -442.7 | 27.4 | -1,616.5% | |
Effective tax rate | % | 3.6 | -1.2 | -298.7% | |
Net profit margin | % | -563.9 | 6.2 | -9,027.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 238 | 1,144,797 | 0.0% | |
Current liabilities | Rs m | 141 | 998,360 | 0.0% | |
Net working cap to sales | % | 963.0 | 8.6 | 11,146.4% | |
Current ratio | x | 1.7 | 1.1 | 147.1% | |
Inventory Days | Days | 207 | 91 | 227.6% | |
Debtors Days | Days | 40,902 | 96 | 42,645.2% | |
Net fixed assets | Rs m | 296 | 553,624 | 0.1% | |
Share capital | Rs m | 75 | 4,172 | 1.8% | |
Net worth | Rs m | 306 | 1,882,824 | 0.0% | |
Long term debt | Rs m | 52 | 866,691 | 0.0% | |
Total assets | Rs m | 534 | 3,873,619 | 0.0% | |
Interest coverage | x | -3.8 | 9.8 | -39.1% | |
Debt to equity ratio | x | 0.2 | 0.5 | 36.8% | |
Sales to assets ratio | x | 0 | 0.4 | 4.3% | |
Return on assets | % | -8.3 | 3.6 | -231.9% | |
Return on equity | % | -18.5 | 5.6 | -329.6% | |
Return on capital | % | -13.1 | 4.9 | -264.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -17 | 270,095 | -0.0% | |
From Investments | Rs m | -13 | -95,706 | 0.0% | |
From Financial Activity | Rs m | 31 | -323,998 | -0.0% | |
Net Cashflow | Rs m | 1 | -149,608 | -0.0% |
Compare VISTA PHARMA With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare VISTA PHARMA With: CAPLIN POINT ALPA LAB TORRENT PHARMA BHARAT PARENTALS GUJ.TERC LAB
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.